Dietary Supplement Adverse Event Reporting—a 10-Year Perspective and Review

CRN - INSIDER Webinar Series
Event Start Date
Nov 15, 2017
Event End Date
Nov 15, 2017
Event Start Time
2 pm Eastern
Event End Time
4 pm Eastern
Webinar

Dietary Supplement Adverse Event Reporting—a 10-Year Perspective and Review

With Natural Products INSIDER | REGISTRATION NOW OPEN

It’s more important than ever that companies understand how FDA and the public view adverse event reports (AERs) and that they have a sophisticated system in place to monitor, report, follow up, and maintain consumer complaints and adverse events. On December 22, 2006, the Dietary Supplement and Nonprescription Drug Consumer Protection Act was signed into law. This law amended the Federal Food Drug & Cosmetic Act to require supplement companies to report serious adverse events to FDA within 15 days of receiving the report, and to keep records of non-serious adverse events for six years. Although the law has been in effect for nearly 10 years and remains unchanged, the industry still faces challenges with regard to how AERs are perceived and interpreted. 

CRN-AER-560x240.jpg

CRN embraced FDA's decision in December 2016 to make public data from FDA’s Center for Food Safety and Applied Nutrition’s (CFSAN) Adverse Event Reporting System (CAERS), calling it a demonstration of the agency’s commitment to transparency. However, the public availability of this data could increase a company’s risk of litigation if the data isn’t properly interpreted or put into context. In addition, a recent study in the Journal of Medical Toxicology misinterpreted poison control center data, providing an inaccurate picture of dietary supplement safety. This webinar will help participants navigate AERs with expert insights on key topics.

Webinar participants will:

  • Receive a brief overview of the AER law and the requirements for dietary supplement businesses
  • Hear FDA’s perspective on AER compliance and response
  • Gain a better understanding of FDA’s increased attention to transparency and industry’s response
  • Learn about the impact of poison control center data in context of AERs
  • Receive practical advice and considerations for in-house AER compliance systems

With:

AER-Canida.jpg

Lyle Canida
Chief, Signals Management Branch, Office of Analytics and Outreach, Center for Food Safety and Applied Nutrition (CFSAN), FDA

 

 

AER-Jackson.jpg

Michelle Jackson
Partner, Venable LLP

 

 

 

AER-Kingston.jpg

Rick Kingston, PharmD.
President, Regulatory and Scientific Affairs, SafetyCall International P.L.L.C.

 

 

AER-Romano.jpgChristina Romano
Product Vigilance Manager, The Nature’s Bounty Co.  

 

 

 

Moderated by:

AER-Al.jpgRend Al-Mondhiry, Esq.
Associate General Counsel, CRN

 

 

 

Learn more about our speakers and REGISTER TODAY here.